Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical condition
|
| gptkbp:abbreviation |
gptkb:MRD
|
| gptkbp:defines |
the small number of cancer cells that remain in the body after treatment
|
| gptkbp:detects |
gptkb:polymerase_chain_reaction
next-generation sequencing flow cytometry |
| gptkbp:field |
oncology
hematology |
| gptkbp:firstDescribed |
1970s
|
| https://www.w3.org/2000/01/rdf-schema#label |
Minimal Residual Disease
|
| gptkbp:measures |
bone marrow
peripheral blood |
| gptkbp:relatedTo |
leukemia
multiple myeloma |
| gptkbp:significance |
prognostic marker
indicator of relapse risk |
| gptkbp:treatmentImplication |
guides therapy decisions
|
| gptkbp:bfsParent |
gptkb:MRD
|
| gptkbp:bfsLayer |
7
|